SCHEMBL4891081

SCHEMBL4891081

CC(C)(C)SCCC(=O)NCc1ccco1

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HPGD P15428 9/20 0.72
ALDH1A1 P00352 7/20 0.72
L3MBTL1 Q9Y468 3/20 0.72
POLB P06746 2/20 0.72
MAPT P10636 2/20 0.72
HSD17B10 Q99714 2/20 0.72
KDM4E B2RXH2 1/20 0.72
PTPN7 P35236 1/20 0.72
SMN1; SMN2 Q16637 2/20 0.53
MEN1 O00255 1/20 0.52
KMT2A Q03164 1/20 0.52
CYP1A2 P05177 2/20 0.52
CYP3A4 P08684 2/20 0.52
CYP2C19 P33261 2/20 0.52
MAPK1 P28482 1/20 0.52
CYP2C9 P11712 1/20 0.52
RAB9A P51151 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4886815 0.84 HPGD (0.78) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL2115850 0.84 HPGD (1.00) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL2926521 0.79 ALDH1A1 (0.69) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL19726938 0.79 HPGD (0.73) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL4886403 0.78 ALDH1A1 (0.48) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL5116644 0.77 HPGD (0.71) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL21630176 0.77 HPGD (0.71) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL29410065 0.77 ALDH1A1 (0.74) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL11479230 0.76 HPGD (0.69) HPGDALDH1A1L3MBTL1POLBMAPT
SCHEMBL6360360 0.76 ALDH1A1 (0.68) HPGDALDH1A1L3MBTL1POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof L'OREAL (FR) 2008-01-31 US disclosed
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof L'OREAL (FR) 2008-01-31 US disclosed
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof L'OREAL (FR) 2008-01-31 US disclosed
EP-1853352-A2 USE OF 3-SULFANYLPROPANAMIDE DERIVATIVES FOR STIMULATING HAIR AND EYELASH GROWTH AND/OR FOR STOPPING THE LOSS AND/OR LIMITING THE DEPIGMENTATION THEREOF L'Oréal (FR) 2007-11-14 EP disclosed
WO-2006079568-A2 USE OF 3-SULFANYLPROPANAMIDE DERIVATIVES FOR STIMULATING HAIR AND EYELASH GROWTH AND/OR FOR STOPPING THE LOSS AND/OR LIMITING THE DEPIGMENTATION THEREOF L'OREAL (FR) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080025940-A1 Administration of 3-sulfanylpropanamide compounds for stimulating hair and eyelash growth and/or for stopping the loss and/or limiting the depigmentation thereof KRT18, TYR, MC1R HPGD 1145/4885ALDH1A1 1607/4885L3MBTL1 4007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.